- Home
- MRSN vs EDAP Comparison
MRSN vs EDAP Comparison
Compare MRSN & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- EDAP
- Stock Information
- Founded
- MRSN 2001
- EDAP 1979
- Country
- MRSN United States
- EDAP France
- Employees
- MRSN N/A
- EDAP N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MRSN Health Care
- EDAP Health Care
- Exchange
- MRSN Nasdaq
- EDAP Nasdaq
- Market Cap
- MRSN 47.1M
- EDAP 46.7M
- IPO Year
- MRSN 2017
- EDAP 1997
- Fundamental
- Price
- MRSN $9.76
- EDAP $2.37
- Analyst Decision
- MRSN Strong Buy
- EDAP Buy
- Analyst Count
- MRSN 3
- EDAP 3
- Target Price
- MRSN $33.00
- EDAP $8.50
- AVG Volume (30 Days)
- MRSN 69.2K
- EDAP 61.6K
- Earning Date
- MRSN 11-12-2025
- EDAP 11-06-2025
- Dividend Yield
- MRSN N/A
- EDAP N/A
- EPS Growth
- MRSN N/A
- EDAP N/A
- EPS
- MRSN N/A
- EDAP N/A
- Revenue
- MRSN $34,769,000.00
- EDAP $74,008,221.00
- Revenue This Year
- MRSN N/A
- EDAP N/A
- Revenue Next Year
- MRSN N/A
- EDAP N/A
- P/E Ratio
- MRSN N/A
- EDAP N/A
- Revenue Growth
- MRSN 16.14
- EDAP 1.56
- 52 Week Low
- MRSN $5.21
- EDAP $1.21
- 52 Week High
- MRSN $70.75
- EDAP $3.08
- Technical
- Relative Strength Index (RSI)
- MRSN 59.67
- EDAP 54.60
- Support Level
- MRSN $8.76
- EDAP $2.23
- Resistance Level
- MRSN $10.49
- EDAP $2.46
- Average True Range (ATR)
- MRSN 0.84
- EDAP 0.22
- MACD
- MRSN -0.06
- EDAP -0.01
- Stochastic Oscillator
- MRSN 56.87
- EDAP 50.25
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.